Questcor Pharmaceuticals Inc. (QSC)

[analogdog]

Questcor swings to Q3 profit
Monday November 12, 6:06 pm ET

Questcor Pharmaceuticals Inc. reported a profit of $8.6 million for the third quarter.

The Union City company (AMEX: QSC - News) lost $1.5 million in the same quarter a year ago.

Sales of the company's H.P. Acthar Gel drug for multiple sclerosis related conditions pushed it to a profit. Questcor recorded $14.6 million in sales of the drug during the quarter, making up the lion's share of the company's third quarter revenue of $14.8 million.

A year ago Questcor had sales of $4 million in the third quarter.

The company is also developing a pain drug, which it hopes to put into clinical trials next year.

Published November 12, 2007 by San Francisco Business Times